iStock_51645852_XLARGE_V9_9.jpg
8.png
8.png
8.png
iStock_51645852_XLARGE_V9_9.jpg

NEXT GENERATION INFECTIOUS DISEASE DIAGNOSTICS


People-centered solution for Dengue fever and Zika diagnostics

SCROLL DOWN

NEXT GENERATION INFECTIOUS DISEASE DIAGNOSTICS


People-centered solution for Dengue fever and Zika diagnostics

 

Combining laboratory accuracy with
user friendly design

 
D3 with app 2.png
 

Always on-line

 
 

3G, Wi-Fi, LAN, Bluetooth and BluSense Cloud enable smart data management

ACCURATE

 
 

Quantitative blood test results with the same accuracy of central laboratories.

QUICK & easy

 
 

From one drop of blood to results in 9 minutes

versatile 

 
 

Compatible with multiple infectious disease diagnostics tests

8.png

NANOTECHNOLOGY ENABLES SMART DIAGNOSTICS


SCROLL DOWN

NANOTECHNOLOGY ENABLES SMART DIAGNOSTICS


Patented TECHNOLOGY

 

Nanoparticles and microfluidics
 

BluSense enables diagnosis of various diseases, through its proprietary technology, using a single drop of blood. 

Combining magnetic nanoparticle physics, microfluidics, and Blu-Ray optics, highly sensitive bio-markers quantification is obtained with a compact detection module. 

 

fully integrated SAMPLE PROCESSING 

All assays and sample treatment steps are carried out without any user interaction.

Using state-of-the-art centrifugal microfluidics technology, a small, disposable, and low cost cartridge allows high accuracy and a very short sample-to-answer-time.

 

ENABLING MINIMALLY-TRAINED OPERATORS

BluBox has been developed on the fingerprint of Blu-Ray players, creating a new diagnostics device characterized by an unprecedented level of usability and attention to the user experience.

 

8.png

AT THE EDGE OF INNOVATION


SCROLL DOWN

AT THE EDGE OF INNOVATION


awarded innovation grants

 

2015

BluSense leads a Eurostars project with 3 international partners for advancing its microflidics capabilities.

 

2015

Horizon 2020 project awarded to Small and Medium Enterprises "among the most innovative in Europe".

 

2014

Pre-exploratory Seed grant awarded by the Novo Nordisk Foundation for research in clinical technology.

2013

European research Council grant for market-oriented research, awarded under the ERC grant of Prof. A. Boisen

 

2013

Proof of Concept grant for commercialization-driven research - Technical University of Denmark.

 

2013

Technology commercialization grant awarded to patent-carrying researchers from DTU.

8.png

DRIVEN BY VISIONARIES, POWERED BY SCIENTISTS


SCROLL DOWN

DRIVEN BY VISIONARIES, POWERED BY SCIENTISTS


ABOUT BLUSENSE

BluSense is a spin-off from one of the leading technical universities of Northern Europe, with a highly skilled and very international mix of founders and employees. A global-born startup, BluSense has operations in Denmark and Taiwan, with scientific and technological partners in 9 different countries worldwide.

BluSense Team BW White BG.png

 

 

 

INVESTMENT OPPORTUNITIES

If you are interested in a highly dynamic and innovative young MedTech company, join our current investors from Denmark, Switzerland, Italy and Taiwan.


CAREERS & INTERNSHIPS

We are constantly looking for motivated, skilled and outgoing people to join our team. We have several available projects suitable for internships and master theses in R&D, production and marketing.

Please visit Nature webpage for more information about current job openings at BluSense.